Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

RB1 Gene Mutation: early-phase trial registry

1 of 1 indexed RB1 Gene Mutation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

RB1 Gene Mutation: 1 US clinical trial tracked, 1 recruiting.

RB1 Gene Mutation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Circle Pharma, running 1 of these trials.

Enrollment posture brief

Registry condition rb1-gene-mutation

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

RB1 Gene Mutation (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near RB1 Gene Mutation

RB1 Gene Mutation lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for RB1 Gene Mutation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. RB1 Gene Mutation is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Circle Pharma 1 trials

Named interventions

Most-linked intervention names on RB1 Gene Mutation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

CID-078 Monotherapy Drug
1 trials

US sites by state

Facility locations filed on RB1 Gene Mutation trials. A trial with sites in several states counts in each.

Utah 1 trials
Texas 1 trials
Tennessee 1 trials
Oregon 1 trials
Ohio 1 trials
Nevada 1 trials
Michigan 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this RB1 Gene Mutation page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 RB1 Gene Mutation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Circle Pharma sponsors the most RB1 Gene Mutation trials on record, review their full trial history before evaluating a specific study. See Circle Pharma's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This RB1 Gene Mutation condition card totals 1 registered trials; most-linked intervention CID-078 Monotherapy; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.